Combat Drugs Limited diagnostics interface makes it easy to digest most current publicly released information about Combat Drugs as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Combat Drugs price relationship with some important fundamental indicators such as market cap and management efficiency.
Combat Drugs Note
The company had not issued any dividends in recent years. Combat Drugs Limited had 1:10 split on September 19, 2011. Combat Drugs Limited manufactures and markets pharmaceutical formulations in India. The company was founded in 1986 and is based in Hyderabad, India. Combat Drugs is traded on Bombay Stock Exchange in India. For more info on COMBAT DRUGS please contact the company at 91 40 6552 3363 or go to http://www.combatdrugs.in.
Combat Drugs Limited Alerts
The company has accumulated 710 K in total debt with debt to equity ratio (D/E) of 3.5 implying the company greatly relies on financing operations through barroing. Combat Drugs Limited has Current Ratio of 0.74 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
COMBAT DRUGS has accumulated about 98 K in cash with (34.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
The company currently falls under 'Small-Cap' category with current market capitalization of 189.6 M.
The company has Profit Margin (PM) of 5.68 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is normal as compared to the sector avarege. Similarly, it shows Operating Margin (OM) of 5.72 % which suggests for every 100 dollars of sales it generated a net operating income of 0.06.
Combat Drugs Limited has return on total asset (ROA) of 0.01 % which means that it generated profit of $0.01 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of 0.03 % meaning that it generated $0.03 on every $100 dollars invested by stockholders.
The output start index for this execution was eleven with a total number of output elements of six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Combat Drugs middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Combat Drugs Limited. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.